Lataa...
What Should an Ideal Vaccine Postlicensure Safety System Be?
In 2007 the National Vaccine Program, along with the Centers for Disease Control and Prevention, the Food and Drug Administration, the National Institutes of Health, and the Health Resources and Services Administration, sponsored a public conference titled “Vaccine Safety Evaluation: Post Marketing...
Tallennettuna:
| Julkaisussa: | Am J Public Health |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Public Health Association
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4504357/ https://ncbi.nlm.nih.gov/pubmed/19797747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2105/AJPH.2008.143081 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|